Cita APA

Kim, C., Lee, C., Chon, H. J., Kim, J. H., Park, H. S., Heo, S. J., . . . Rha, S. Y. (2017). PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer. Oncotarget.

Citación estilo Chicago

Kim, Chan, et al. "PTEN Loss and Level of HER2 Amplification Is Associated With Trastuzumab Resistance and Prognosis in HER2-positive Gastric Cancer." Oncotarget 2017.

Cita MLA

Kim, Chan, et al. "PTEN Loss and Level of HER2 Amplification Is Associated With Trastuzumab Resistance and Prognosis in HER2-positive Gastric Cancer." Oncotarget 2017.